Thyroid Cancer Trial, Recruiting NCT02747888 Sponsor: Dana-Farber Cancer Institute Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT02747888
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers (under 18) who currently have, or have previously had, a known or suspected thyroid cancer or thyroid nodule(s).
  • Adults who currently have, or have previously had, a known or suspected thyroid cancer or thyroid nodule(s), if they come from a family where hereditary cancer is strongly suspected.
  • People from families where a child (under 18) has currently or previously been diagnosed with thyroid cancer or a thyroid nodule.
  • People from families where more than one family member has had thyroid cancer.
  • People from families where thyroid cancer has occurred alongside a known or suspected genetic condition (for example, families with multiple childhood cancers, multiple different cancers in one person, or multiple hormone-related conditions).

Who may not be able to join:

  • People who are not able to give informed consent to take part in the study.
  • People who are not able to complete the study materials required for participation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Junne Kamihara, MD, PhD, Dana-Farber Cancer Institute

Phone: 617.632.3044

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2016
Est. completion
1 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants who have childhood or suspected familial thyroid nodules/cancer; Number of germline mutations identified associated with thyroid cancer predisposition; Prevalence of suspected familial thyroid cancer among those with childhood thyroid nodules/cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov